Filter
946
Text search:
nCOV
Featured
199
3
Language
Document type
529
117
108
69
37
23
15
12
10
9
9
7
1
Countries / Regions
81
59
48
41
35
32
31
31
29
28
27
27
24
22
19
17
16
13
12
9
9
9
9
8
8
8
7
7
7
7
6
6
6
6
5
5
5
4
4
4
4
4
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
425
20
18
17
16
11
7
Toolboxes
850
16
16
12
10
6
6
5
4
4
3
2
2
2
2
1
1
1
1
Accessed: 16.03.2020
CONVIDECIA is based on a modified human adenovirus that expresses the spike S protein of SARS-CoV-2. It is administered as a single dose.
Este documento resume as orientações provisórias da OMS para a vigilância global de novas infecções pelo coronavírus 2019-nCoV (COVID-19). A OMS continuará atualizando essas orientações à medida que novas informações sobre 2019-
...
Countries who have no testing capacity can send their samples to the WHO appointed 2019-nCoV referral laboratories for testing. National 2019-nCoV laboratories with limited experience are encouraged
...
BMJ is offering a range of free online resources to support researchers, doctors, nurses, and other healthcare professionals to understand and respond to the global health emergency caused by the novel coronavirus (2019-nCoV).
The free online res
...
Social distancing is an action taken to minimise contact with other individuals; social distancing measures comprise one category of non-pharmaceutical countermeasures (NPCs)1 aimed at reducing disease transmission and thereby also reducing pressure on health services.
This document builds upon exi
...
This algorithm shows the main actions for contacts of probable or confirmed 2019-nCoV cases. Implementation may be modified depending on the risk assessment for individual cases and their contacts by public health authorities.
The Global Health Network is an open source platform that provides trusted knowledge, guidance, tools and resources to support the generation of more and better health research data. During emerging outbreaks it is vital to learn as much as possible to generate evidence on best practice for preventi
...
Manufacturers:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)]
Efficacy shown in clinical trials in participants w
...
16.7.2021
Medizinische KlinikIntensivmedizin und Notfallmedizin
https://doi.org/10.1007/s00063-020-00674-3
16.7.2021
16-24 February 2020
Accessed: 26.03.2020
Тридцать первого декабря 2019 г. ВОЗ получила информацию о случаях пневмонии неясного происхождения (причина неизвестна), выявленных в г. Ухань китайско
...
7 April 2020. This document and risk assessment tool provides practical guidance and recommendations to support the special role of religious leaders, faith-based organizations, and faith communities in COVID-19 education, preparedness, and response.
You can download the risk assessment tool here:
...
Временные рекомендации
24 февраля 2020 г.
Настоящий документ подготовлен с использованием имеющихся в настоящее время фактологических данных о передаче коронави
...
WHO-2019-nCoV-genomic_sequencing
